Drug Information

Drug General Information
Drug ID
D05VXF
Former ID
DIB013596
Drug Name
YSCMA
Synonyms
YS-110; Anti-CD26 humanized antibody (cancer), Y's Therapeutics/Kissei Pharmaceutical
Drug Type
Antibody
Indication Hematological malignancies [ICD9: 200-209; ICD10:C81-C86] Phase 1/2 [548989]
Company
Y's Therapeutics Co Ltd
Target and Pathway
Target(s) Dipeptidyl peptidase IV Target Info [532663]
KEGG Pathway Protein digestion and absorption
NetPath Pathway IL2 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
References
Ref 548989Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031210)
Ref 532663Establishment of monoclonal anti-human CD26 antibodies suitable for immunostaining of formalin-fixed tissue. Diagn Pathol. 2014 Feb 6;9:30.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.